<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Zymergen, Inc. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=27978></link><description><![CDATA[Zymergen, Inc. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 01:22:14 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2016/10/3554153577_20161011171809_4701921355.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Zymergen Announces $130 Million in Series B Funding, Led by SoftBank]]></title><link>https://www.newswire.co.kr/newsRead.php?no=837099</link><description><![CDATA[EMERYVILLE, Calif.--(Business Wire/Korea Newswire)--Zymergen, a technology company unlocking the power of biology, announced today that it has raised 130 million USD in Series B funding led by SoftBank Group (TOKYO: 9984). The round also includes prior lead investor Data Collective (DCVC), as well as return investors True Ventures, AME Cloud Ventures, DFJ, Innovation Endeavors, Obvious Ventures, ...]]></description><pubDate>Tue, 11 Oct 2016 17:25:00 +0900</pubDate></item><item><title><![CDATA[자이머젠, 소프트뱅크가 주도한 시리즈 B 펀딩에서 1억 3000만 달러 모금]]></title><link>https://www.newswire.co.kr/newsRead.php?no=837100</link><description><![CDATA[에머리빌, 캘리포니아--(Business Wire/뉴스와이어)--바이올로지 관련 기술 기업인 자이머젠(Zymergen)이 오늘 소프트뱅크가 주도한 시리즈 B 펀딩에서 1억 3000만 달러를 모금했다고 발표했다.   이번 펀딩 라운드는 전 주요 투자기업인 데이터 콜렉티브(Data Collective, DCVC)와 돌아온 투자기업, 트루벤처(True Ventures), AME 클라우드 벤쳐(AME Cloud Ventures), DFJ, 이노베이션 인데버(Innovation Endeavors), 오브비어...]]></description><pubDate>Tue, 11 Oct 2016 17:25:00 +0900</pubDate></item></channel></rss>